In her new role, Subbiah will focus on the reduction of cancer outcomes disparities and the diversification of clinical trial participation within SCRI’s combined research network, which comprises over 1,300 physicians in more than 250 locations across the US.

Howard A Burris III MD, president of SCRI, commented: “Participating in a clinical trial is the first step in fighting cancer, and we must ensure that more patients – especially underserved populations – can access these treatment options. With Ishwaria’s leadership, we can implement strategies to reduce barriers while accelerating drug development and improving patient outcomes.”

Commenting on her new role, Dr Subbiah said: “Broadening access to high-quality cancer care and cutting-edge cancer therapies on clinical trials is possible by bringing all stakeholders to the same table and enacting changes together. With SCRI’s national reach, we have the ability to develop transformational approaches to diversify clinical trial recruitment and reduce care disparities at an unprecedented scale. At the same time, we have an opportunity to also focus on workplace experiences for thousands of clinicians engaged in research across SCRI’s network. By strengthening our workforce, we can strengthen the fight against cancer for every individual we treat.”